Navigation Links
Mach One Corporation Announces Completion of Final Tests Prior to Full Scale Production
Date:4/3/2008

WEST BEND, Wis., April 3, 2008 /PRNewswire-FirstCall/ -- Mach One Corporation, http://www.machonecorp.com, (Pink Sheets: MNCN) announces that the final tests prior to large scale manufacturing of its ImmunoGam(TM) colostrum replacement product were completed last week.

"A highly qualified scientist from BioQual spent a week with us in our Belgium, Wisconsin facility completing a technology transfer and memorializing the protocols for manufacture of our flagship product ImmunoGam(TM)" stated Monte Tobin, President of Mach One. "The BioQual scientist couldn't believe the progress we have made in taking their original concept of colostrum replacement for the equine industry and adapting it through our own science to the dairy industry with ImmunoGam(TM). These newly designed protocols should revolutionize the colostrum replacement industry and in keeping with our corporate philosophy we will be 'building a better herd, one calf at a time(TM)'."

"ImmunoGam (TM) is a product that could be used for the nine million dairy calves born each year," continued Tobin, "This replacement product can be used as a time saving management tool for large dairies that have as many as 15 to 50 calves being born each day throughout a year. We see this as a great opportunity to strengthen the health of dairy cattle as a whole and to allow the dairyman to see full yields from his herd. Production in bulk should start within the next 10 days."

About Mach One Corporation

Through its wholly-owned subsidiary VDx, Inc. (http://www.vdxinc.com), the company will manufacture and sell Immunogam (TM), a colostrums replacement, supplement and prophylactic, in sterile powder form, which can be administered orally or intravenously. VDx is also further developing a proprietary procedure to allow for large scale manufacturing of colostral replacement products for market that includes an added ingredient for elimination of mastitis and Johnnes disease.

The IgG replacement market is estimated at 1.1 billion dollars per year.

Safe Harbor Statement

This press release contains forward-looking information. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's SEC reports. These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected.


'/>"/>
SOURCE Mach One Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , ... May 25, 2016 , ... America Walks ... Carol Reichbaum, M.S.L., M.S.P.A., of the University of Pittsburgh Graduate School of Public ... will enable Ms. Reichbaum and 24 other advocates from around the country to participate ...
(Date:5/25/2016)... , ... May 25, 2016 , ... Researchers from SUNY ... COVD Meeting for their work on visual evoked potential and human attention. The article, ... that used the Diopsys® NOVA™ ERG and VEP Vision Testing System (Diopsys, ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... demand for minimally invasive, endoscopic spine surgeries in the Montgomery County, Howard County ... patients in the Germantown office of American Spine every Monday. He will also ...
(Date:5/24/2016)... , ... May 24, 2016 , ... To better understand ... new research award to examine gender differences in lung cancer. Today, the Lung Association ... Project: Lung Cancer in Women Award, funded by the American Lung Association’s LUNG FORCE ...
(Date:5/24/2016)... ... May 24, 2016 , ... United Benefit Advisors (UBA), the ... Firm Austin & Co., Inc. Headquartered in Albany, New York, Austin & ... benefits technology, and beyond. As an employee-owned company celebrating over 160 years ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 2016  Granger Diagnostics today announced immediate availability of ... infections. This test ensures discovery of ALL bacteria, ... test requires only a simple swab of the wound ... G. Bostwick , MD, Chief Medical Officer, described ... "We are excited to make available, for the ...
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/25/2016)... May 25, 2016 ReportsnReports.com ... research report that provides an overview on therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
Breaking Medicine Technology: